Tudor Health brings together expertise from all sides of the life science sector to create a novel approach to capturing and delivering quality patient data.
Tudor Health was founded in 2021. The founding principals were the closure of gaps in commercial data, especially for oncology and rare diseases. Industry and agency expertise was brought to the problem and, after a period of R&D and proof-of-concept testing, Tudor Health started commercial operations in 2023.
The methods and techniques we use are based on an evolution of tried and tested methods combined with innovations in data capture, sampling and business model that create the value our clients welcome.
Our data capture is NOT drawn directly from EMR software. This allows us to capture data from institutions with any EMR technology. We establish a strong relationship with individual HCPs to capture data, not a technology link.
Our longitudinal data are captured by updating data on the same set of patients. This gives us the opportunity to gradually expand the extent of the data held on each patient, which gives us greater depth of analytical options.
We offer expertly curated patient-level data for specialised disease cohorts. Our data allows lifescience professionals to make more informed decisions and improve results in rare and complex conditions.
With our global network and extensive partnerships, we are able to provide access to a greater number of patients across more countries than ever before. This allows for more comprehensive and reliable data to support your research and commercial decisions.
Our team is dedicated to supporting the commercialisation and drug development efforts in specialised and niche markets. We provide expert guidance and tailored solutions to help your business navigate the unique challenges and opportunities of these complex markets.
We are revolutionising the way clinical histories are generated by using a patient-centric approach. Our cutting-edge technology allows us to quickly and accurately capture genotype and phenotype data, providing a complete picture of a patient’s health history. This helps lifescience professionals make more informed decisions.
Unlike traditional, monolithic systems, Tudor Health offers a more flexible and targeted approach to disease cohort analysis and monitoring. Our innovative technology allows us to quickly and accurately identify and track specific disease cohorts, providing valuable insights and enabling more effective decision making over time.
Our company was founded by a team of experienced data scientists and healthcare experts who are passionate about improving patient care in specialised markets. With our deep knowledge and advanced technology, we are able to provide comprehensive and reliable data to support the unique needs of these complex markets.
We use complex sampling techniques to ensure that we have sufficient data on rare cohorts to give analytical reliability. By over-sampling rare cohorts we provide insights at a level that other sources find difficult.
The Tudor Health data model uses an identical data-capture method in all countries. This makes the data consistent within country and comparable across countries.
Tudor Health is led by Simon Fitall, our founding CEO
Simon is an accomplished executive with a deep understanding of data and data analytics and a passion for educating others. His career started at A.C. Nielsen, progressed to OTC product management, and later into market research with Taylor Nelson. Simon founded Marketing Resources International, specializing in data analytics, modelling, and forecasting. This venture marked the beginning of his public speaking engagements, journal publications, and training courses aimed at enhancing knowledge and skills in the field of data analytics.
During his tenure at MRI, Simon honed his skills in quantitative and qualitative research techniques, working with leading pharmaceutical and biotech companies to create analytical market models. This role evolved into a co-founder position at Galileo Analytics, a company focused on visualising and analysing health data. As CEO of health data start-up Tudor Health, Simon continues to break new ground, creating innovative data capture, analysis, and delivery models. He is also the CEO of Galileo Analytics and has pioneered tools to support various areas of healthcare, including drug and device development. In addition to running multiple training programs for various organisations, Simon has had numerous papers, publications, and workshops published. He also served as the editor of the first edition of the University of Georgia/MRII online training program for Pharmaceutical Marketing Research. Simon’s experience, innovation, and dedication to education are underpinned by a relentless pursuit of knowledge and a commitment to sharing this knowledge for the benefit of others. Simon lives in France and is a very keen walker and photographer
Understanding Health Equity Let’s explore the significance of health equity and why it has become…
Tudor Health is delighted to announce that data scientist John Elhagar has joined our growing…
Government Control The organisation and management of the health care system is different in each…
Our data is sourced from all countries and specifically targets small cohorts and rare diseases, making it perfect for commercial use.
Tudor Health Inc, 1100 H St NW, Suite E-101, Washington DC 20005, USA
Simply enter your name and email below to receive occasional emails with news and industry insight.*
*Your information will only be used to send our newsletter. It wont be sold or passed to any third party. Obviously, you can unsubscribe at any time!